Antigen Concentrations as an Indicator of Clinical Remission and Disease Relapse in Cats with Histoplasmosis

Background Treatment monitoring is subjective and disease relapse is common in cats with histoplasmosis. The Histoplasma antigen enzyme immunoassay (EIA) is a noninvasive test used for determining disease remission and detecting disease relapse in humans with histoplasmosis. The utility of the antigen EIA for these purposes in cats remains unknown. Hypothesis/Objectives Those Histoplasma antigen concentrations in urine and serum would decline with antifungal treatment and that antigen elimination would be an indicator of clinical remission in cats with histoplasmosis treated with antifungal treatment. Animals Fifteen client‐owned cats with histoplasmosis. Methods Masked observational study. Cats were monitored monthly during antifungal treatment. Time of clinical remission and serum and urine antigen elimination were determined for each cat. Results Twelve of 15 cats achieved clinical remission. At the time of diagnosis, antigen was detectable in urine in 14/15 (93%) cats and in serum in 11/15 (73%) cats. Both serum (P < .0005) and urine (P < .0001) antigen concentrations significantly decreased over time with effective treatment. Antigen elimination was sensitive [urine, 90.0% (95% CI 72.3–97.4%); serum, 90.4% (68.2–98.3%)] but less specific [urine, 64.6% (51.7–75.8%); serum, 52.1% (37.4–66.5%)] for disease remission. Urine antigen was positive in both cats and serum antigen was positive in 1 cat at the time of disease relapse. Conclusions and Clinical Importance Measurement of Histoplasma antigen in urine and serum might be useful tests for determining disease remission and relapse in cats with histoplasmosis. Further research is needed to investigate the importance of low‐level antigenemia and antigenuria.

[1]  M. Money,et al.  Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Theel,et al.  Clinical Significance of Low-Positive Histoplasma Urine Antigen Results , 2014, Journal of Clinical Microbiology.

[3]  K. Harkin,et al.  Feline histoplasmosis: fluconazole therapy and identification of potential sources of Histoplasma species exposure , 2012, Journal of feline medicine and surgery.

[4]  L. Wheat,et al.  Clinical evaluation of urine Histoplasma capsulatum antigen measurement in cats with suspected disseminated histoplasmosis , 2012, Journal of feline medicine and surgery.

[5]  K. Aulakh,et al.  Feline histoplasmosis: a retrospective study of 22 cases (1986-2009). , 2012, Journal of the American Animal Hospital Association.

[6]  N. E. Babady,et al.  A multicenter evaluation of tests for diagnosis of histoplasmosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Baddley,et al.  Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay , 2011, Clinical and Vaccine Immunology.

[8]  M. Brandt,et al.  Diagnosis of acute pulmonary histoplasmosis by antigen detection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Kauffman.  Diagnosis of histoplasmosis in immunosuppressed patients , 2008, Current opinion in infectious diseases.

[10]  L. Wheat,et al.  Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay , 2007, Clinical and Vaccine Immunology.

[11]  J. Baddley,et al.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Yiannoutsos,et al.  Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  T. Davis,et al.  Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole , 2001, Antimicrobial Agents and Chemotherapy.

[14]  D. Schaeffer,et al.  Use of corticosteroids for treating dogs with airway obstruction secondary to hilar lymphadenopathy caused by chronic histoplasmosis: 16 cases (1979-1997). , 1999, Journal of the American Veterinary Medical Association.

[15]  J. Meinkoth,et al.  Cytology of Post-Treatment Histoplasmosis , 1997 .

[16]  J. Meinkoth,et al.  What is your diagnosis? Cytology of post-treatment histoplasmosis , 1997 .

[17]  G. Troy,et al.  Deep mycotic infections in cats. , 1996, Journal of the American Animal Hospital Association.

[18]  L. Adams,et al.  Itraconazole for the treatment of histoplasmosis in cats. , 1994, Journal of veterinary internal medicine.

[19]  B. Katz,et al.  Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. , 1991, Annals of internal medicine.

[20]  K. Clinkenbeard,et al.  Disseminated histoplasmosis in dogs: 12 cases (1981-1986). , 1988, Journal of the American Veterinary Medical Association.

[21]  K. Clinkenbeard,et al.  Disseminated histoplasmosis in cats: 12 cases (1981-1986). , 1987, Journal of the American Veterinary Medical Association.

[22]  M. Furcolow,et al.  The efficiency of serologic and cultural methods in the detection of infection with Histoplasma and Blastomyces in mongrel dogs. , 1972, Sabouraudia.

[23]  C. Smith,et al.  Correlation of Fluorescent Antibody, Histopathology, and Culture on Tissues from 372 Animals Examined for Histoplasmosis and Blastomycosis , 1965, Journal of bacteriology.